+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Indian Pharma Sector Forecast 2026

  • PDF Icon

    Report

  • 100 Pages
  • June 2022
  • Region: India
  • RNCOS E-Services Private Limited
  • ID: 5614318
The Indian pharma industry has always been a leading industrial sector in the country, with a paralleled dominance of both domestic and foreign pharma companies. As a result of the vast potential held by the industry, it was estimated to have generated revenue worth US$ 49 Billion in FY 2021. Growing population of middle-class, rapid shift towards urbanization, enhanced medical infrastructure, increase in health insurance and lifestyle-related disease are some of the major factors for the growth of the industry.

According to this new research report “Indian Pharma Sector Forecast 2026”, the rise in continuous investments by multinational companies and exports project a double-digit growth in near future. A large percentage of pharma products produced in India are exported, which has led the leading players to expand their reach into the Western nations. Due to the investments in R&D and the quest for more and more ANDA filings, the clinical trials market is growing at blistering pace. For comprehensive outlook of the industry, our in-depth and extensive research covers various segment ranging from the export and domestic market, bulk drugs & formulations to branded & generic drugs, etc.

The progress in the reach to medicines among Indians sets the baseline for the optimistic future outlook of the pharmaceutical market. The focus of the industry will shift towards capitalizing the potential of Tier-III and rural areas. Sectors such as biosimilars and CRAMS will continue pave way for the pharmaceutical market during the forecast period (FY 2022-2026).

The report offers a comprehensive statistical and analytical overview of the Indian pharmaceutical industry. It offers data on past, present, and future trends, with a focus on the pharmaceutical market's overall structure, makeup, and operation. The research goes into great detail about the opportunities and challenges that are predicted to occur both within and outside the pharmaceutical industry.

The research also looks at the pharmaceutical industry's regulatory framework and distribution structure. It has thoroughly investigated current market trends, developments, and competitive landscapes in order to help clients comprehend the market structure and its trajectory in the coming years. It also gives a quick rundown of the demographics and healthcare profile in order to assess the pharmaceutical market in terms of demand, spending, and potential future direction.

Table of Contents

1. Analyst View2. Research Methodology
3. Market Drivers
3.1 Macroeconomic & Demographic Profile
3.2 Product Patent Regime
3.3 Medical Infrastructure
3.4 Prevalence of Lifestyle-related Diseases
4. Indian Pharmaceutical Industry
4.1 Industry Overview
4.2 Domestic & Exports Market
4.3 Future Outlook
5. Market Segmentation
5.1 Patented & Generics
5.2 Type of Drugs
5.2.1 Bulk Drugs/APIs
5.2.2 Formulations
5.3 By Therapeutics
5.3.1 Acute Segment
5.3.1.1 Anti-Infectives
5.3.1.2 Gastrointestinal
5.3.1.3 Vitamins/Minerals/Nutrients
5.3.1.4 Pain/Analgesics
5.3.1.5 Dermatology
5.3.1.6 Gynecology
5.3.1.7 Respiratory
5.3.2 Chronic Segment
5.3.2.1 Cardiac
5.3.2.2 Neuro/CNS
5.3.2.3 Anti-Diabetic
6. Distribution Channel Analysis
7. Regulatory Overview
7.1 Industry Regulations
7.2 Government Initiatives
7.2.1 Union Government
7.2.2 State Government
8. Growth Accelerators
8.1 Biosimilar
8.2 CRAMS
8.3 Bioinformatics
8.4 Clinical Trials
8.5 Pharma Packaging Industry
9. Competitive Landscape
9.1 Market Structure
9.2 Mergers & Acquisitions
9.3 Key Players Analysis
9.3.1 Aurobindo Pharma
9.3.2 Cipla Limited
9.3.3 Dr. Reddys Labs
9.3.4 Sun Pharma
9.3.5 Lupin Ltd.
List of Tables:
Table 3-1: Macroeconomic Overview (2017-2021)
Table 3-2: Demographic Characteristics (2017-2021)
Table 4-1: Top 10 Countries for Exports of Pharmaceuticals (FY 2021)
Table 8-1: Leading Approved Biosimilars India
Table 9-1: Key Acquisitions in Pharmaceutical Industry
Table 9-2: Aurobindo Pharma - Key Financials (Billion INR), FY 2019 to FY 2021
Table 9-3: Cipla Limited - Key Financials (Billion INR), FY 2019 to FY 2021
Table 9-4: Dr. Reddys Labs - Key Financials (Billion INR), FY 2019 to FY 2021
Table 9-5: Sun Pharma - Key Financials (Billion INR), FY 2019 to FY 2021
Table 9-6: Lupin - Key Financials (Billion INR), FY 2019 to FY 2021
List of Figures:
Figure 3-1: FDI Equity Inflow (Billion US$), FY 2017 to FY 2022
Figure 3-2: FDI Equity Inflow in Pharmaceuticals (Billion US$), FY 2020 to FY 2022
Figure 4-1: Pharmaceutical Industry (Billion US$), FY 2016 to FY 2021
Figure 4-2: Breakup of Pharmaceutical Industry (%), FY 2021
Figure 4-3: Domestic Pharmaceutical Market (Billion US$), FY 2016 to FY 2021
Figure 4-4: Export of Pharmaceuticals (Billion US$), FY 2016 to FY 2021
Figure 4-5: Pharmaceutical Exports by Segment (%), FY 2021
Figure 4-6: Domestic Pharmaceutical Market (Billion US$), FY 2022 to FY 2026
Figure 4-7: Worldwide Total Prescription Drug Revenue at Risk from Patent Expiration (Billion US$), 2022-2026
Figure 5-1: Domestic Drug Formulations Market by Category (%), FY 2026
Figure 5-2: Bulk Drugs Export (Billion US$), FY 2016 to FY 2021
Figure 5-3: Domestic Drug Formulations Market (Billion US$), FY 2016 to FY 2021
Figure 5-4: Drug Formulations Export (Billion US$), FY 2016 to FY 2021
Figure 5-5: Domestic Pharmaceutical Market by Therapeutic Category (%), FY 2021
Figure 5-6: Anti-Infectives Market (Million US$), FY 2021 & FY 2026
Figure 5-7: Gastrointestinal Drugs Market (Million US$), FY 2021 & FY 2026
Figure 5-8: Vitamins/Minerals/Nutrients Market (Million US$), FY 2021 & FY 2026
Figure 5-9: Pain/Analgesics Market (Million US$), FY 2021 & FY 2026
Figure 5-10: Dermatology Market (Million US$), FY 2021 & FY 2026
Figure 5-11: Gynecology Market (Million US$), FY 2021 & FY 2026
Figure 5-12: Number of Asthma Patients (Million), 2020 & 2030
Figure 5-13: Respiratory Drugs Market (Million US$), FY 2021 & FY 2026
Figure 5-14: Cardiac Drugs Market (Million US$), FY 2021 & FY 2026
Figure 5-15: Neuro/CNS Drugs Market (Million US$), FY 2021 & FY 2026
Figure 5-16: Number of adults (20-79 years) with Diabetes (Million), 2021 & 2045
Figure 5-17: Anti-Diabetic Market (Million US$), FY 2021 & FY 2026
Figure 6-1: Pharmaceutical Distribution Channel
Figure 8-1: Contract Manufacture and Research Services Market (Billion US$), 2018 to 2026
Figure 8-2: Number of Registered Clinical Trials (2011-2017)
Figure 8-3: Number of Approved Clinical Trials (2013 & 2021)
Figure 8-4: Clinical Trials by Phase (%)
Figure 8-5: Clinical Trials by Condition (%)
Figure 8-6: Clinical Trials Market (Billion US$), 2021-2026
Figure 8-7: Pharma Packaging Market (Million US$), 2021-2026
Figure 9-1: Share of Leading Companies in Pharmaceutical Market (FY 2021)

Companies Mentioned

  • Aurobindo Pharma
  • Cipla Limited
  • Dr. Reddys Labs
  • Sun Pharma
  • Lupin Ltd.